A study published in the International Journal of Neuropsychopharmacology (2013) stated that Cannabidiol (CBD), the main non-psychotomimetic component of the plant Cannabis sativa, exerts therapeutically promising effects on human mental health such as inhibition of psychosis, anxiety and depression. The study found that the therapeutic potential of non-psychoactive cannabinoids in anxiety and depression, and in particular
Study: Cannabidiol (CBD Oil) reduces intestinal inflammation through the control of neuroimmune axis.
US National Library of Medicine National Institutes of Health Author information Department of Experimental Pharmacology, University of Naples FEDERICO II, Naples, Italy. Abstract Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferate and release neurotrophins, growth factors, and pro-inflammatory cytokines which, in turn, may amplify the immune response, representing